nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—GABRA2—conduct disorder	0.973	1	CbGaD
Quinidine barbiturate—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00322	0.12	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00197	0.0733	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00156	0.0579	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—GABRA2—conduct disorder	0.00135	0.0502	CbGpPWpGaD
Quinidine barbiturate—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00105	0.0389	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000801	0.0298	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—DRD4—conduct disorder	0.000714	0.0266	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—COMT—conduct disorder	0.00065	0.0242	CbGpPWpGaD
Quinidine barbiturate—KCNK1—Neuronal System—MAOA—conduct disorder	0.000646	0.024	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.00061	0.0227	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000602	0.0224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0006	0.0223	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000481	0.0179	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Monoamine GPCRs—HTR2A—conduct disorder	0.000466	0.0173	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—GABRA2—conduct disorder	0.000461	0.0172	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000428	0.0159	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000425	0.0158	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000412	0.0153	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—GABRA2—conduct disorder	0.000408	0.0152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000392	0.0146	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000383	0.0142	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000362	0.0134	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00032	0.0119	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—DRD4—conduct disorder	0.000317	0.0118	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00031	0.0115	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000306	0.0114	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00029	0.0108	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000288	0.0107	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00028	0.0104	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000277	0.0103	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000261	0.0097	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000253	0.0094	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—COMT—conduct disorder	0.000222	0.00826	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAOA—conduct disorder	0.000221	0.0082	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000219	0.00815	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000211	0.00784	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000211	0.00784	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Other—HTR2A—conduct disorder	0.000207	0.0077	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000204	0.00759	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000203	0.00754	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—COMT—conduct disorder	0.000196	0.00729	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAOA—conduct disorder	0.000195	0.00724	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000174	0.00647	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000173	0.00645	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000173	0.00643	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000172	0.00639	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000165	0.00614	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—CGA—conduct disorder	0.000161	0.00597	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—COMT—conduct disorder	0.000156	0.00581	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAOA—conduct disorder	0.000155	0.00577	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000149	0.00554	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—DRD4—conduct disorder	0.000149	0.00552	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000138	0.00514	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000138	0.00513	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000135	0.005	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000134	0.00498	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—COMT—conduct disorder	0.000133	0.00496	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAOA—conduct disorder	0.000132	0.00492	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000118	0.00439	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—COMT—conduct disorder	9.28e-05	0.00345	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—MAOA—conduct disorder	9.21e-05	0.00343	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	9.15e-05	0.0034	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	9.1e-05	0.00339	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—CGA—conduct disorder	9.08e-05	0.00337	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.99e-05	0.00334	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—DRD4—conduct disorder	8.99e-05	0.00334	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—CGA—conduct disorder	8.24e-05	0.00306	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.71e-05	0.00287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	7.13e-05	0.00265	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	5.87e-05	0.00218	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—EP300—conduct disorder	5.49e-05	0.00204	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	5.08e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CGA—conduct disorder	4.87e-05	0.00181	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—DRD4—conduct disorder	4.62e-05	0.00172	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—WASF1—conduct disorder	3.9e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CGA—conduct disorder	3.52e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	3.32e-05	0.00123	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	3.01e-05	0.00112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—DRD4—conduct disorder	2.73e-05	0.00101	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HTR2A—conduct disorder	1.78e-05	0.000662	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—COMT—conduct disorder	1.59e-05	0.00059	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—MAOA—conduct disorder	1.58e-05	0.000586	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EP300—conduct disorder	9.43e-06	0.00035	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—EP300—conduct disorder	6.81e-06	0.000253	CbGpPWpGaD
